BFEC
PHAS

Benjamin F. Edwards & Company’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Benjamin F. Edwards & Company’s Portfolio PHAS Stock Details PHAS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,000
Closed -$6K – 1929
2019
Q4 		$6K Buy
+1,000
New +$6K ﹤0.01% 1583